BCL2L1 and breast carcinoma: Western blotting analysis revealed that only Bcl-xL protein level is dramatically decreased by LCL85 in metastatic human colon cancer cells (Figure 9A), and in the metastatic breast cancer cells, albeit to a less degree (Figure 9B).